The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

  • Research Groups
    • Brown Group

      Lorena’s group is dedicated to understanding different aspects of influenza virus structure and replication, as well as the host immune response to the virus that may impact on disease outcome. They study areas of vulnerability that can be targeted by vaccines and therapeutics to control seasonal and highly pathogenic isolates.


    • Deng Group

      While her team’s core task has always been on the molecular surveillance of influenza viruses and its methodology development, Yi-Mo’s group have been collaborating actively both within and outside the Centre on several research projects relating to the molecular characterisation and evolution of human or animal influenza viruses. 


    • Doherty Group

      Peter has been working consistently in the areas of T cell and viral immunology since the early 1970’s. His work focuses on cellular and molecular aspects of virus-specific CD8+ T cells. Peter’s studies provide insights into acquisition of effector functions by CD8+ T cells, immunodominance, persistence of memory CD8+ T cells and their subsequent recall.

      Other work areas include: Immunology


    • Hurt Group

      Aeron’s research team at the WHO Collaborating Centre for Reference and Research on Influenza works on aspects of understanding the replication and transmission of drug resistant influenza viruses, characterising novel drug resistance mutations, and the global movement and evolution of human and avian influenza viruses.


    • Kedzierska Group

      Katherine’s team researches the immunity to viral infections, especially the newly emerged influenza viruses. Her work spans basic research – from mouse experiments to human immunity, through to clinical settings, with a particular focus on understanding universal CD8+ T cell immunity to influenza viruses. Her studies aim to identify key correlates of severe and fatal influenza disease in high-risk groups including children, the elderly and Indigenous Australians. 

      Other work areas include: Immunology


    • Kent Group

      Stephen’s group studies immunity to HIV and influenza. They are analysing a variety of vaccine strategies, including nanoparticle-based vaccines. They are studying a series of immune responses to gain better insights into protective immunity to important viral pathogens.

      Other work areas include: HIV, Immunology


    • Laurie Group

      Karen’s group investigates the interplay between the immune response and influenza viruses. They assess how the innate and adaptive immune responses control or prevent virus infection and develop strategies to enhance, mimic or improve these mechanisms.

      Other work areas include: Immunology


    • Reading Group

      Patrick’s group investigates how the body first detects and responds to respiratory viruses. They investigate viral attachment factors, cellular receptors and entry pathways, virus-induced activation of host genes and the mechanisms by which intracellular host proteins can block virus replication.

      Other work areas include: Immunology


    • Sullivan Group

      Sheena’s epidemiology group at the WHO Collaborating Centre for Reference and Research on Influenza undertakes research into understanding influenza vaccine effectiveness and the validity of the methods used to estimate it. The group also provides technical assistance to partners in the Western Pacific Region of the WHO. 


    • Wakim Group

      Linda’s group’s main research focus is understating the mechanism of action and regulation of expression of antiviral proteins. Linda’s group also aims to characterise CD8 T cell responses within the lung following virus infection. 

      Other work areas include: Immunology


    Clinical Research

    Anyone can be infected by influenza, but some people are more susceptible to infection, severe disease and clinical complications. Clinical studies at the Doherty Institute are focused on specific risk groups, seeking to understand characteristics of viruses and the immune system that result in increased susceptibility and clinical severity. In particular, current studies are considering:

    Doherty Institute researchers are also characterising immune responses to influenza vaccination or infection in various groups of people, including: